• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ配体可降低流体静压诱导的血小板聚集和促炎活性。

PPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activity.

作者信息

Rao Fang, Yang Ren-Qiang, Chen Xiao-Shu, Xu Jin-Song, Fu Hui-Min, Su Hai, Wang Ling

机构信息

Department of Cardiology, Guangdong General Hospital, Guangzhou, PR China ; Guangdong Academy of Medical Sciences, Guangzhou, PR China.

Department of Cardiology, The second affiliated hospital of Nanchang University, Nanchang, PR China.

出版信息

PLoS One. 2014 Feb 28;9(2):e89654. doi: 10.1371/journal.pone.0089654. eCollection 2014.

DOI:10.1371/journal.pone.0089654
PMID:24586940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3938478/
Abstract

Hypertension is known to be associated with platelet overactivity, but the direct effects of hydrostatic pressure on platelet function remain unclear. The present study sought to investigate whether elevated hydrostatic pressure is responsible for platelet activation and to address the potential role of peroxisome proliferator-activated receptor-γ (PPARγ). We observed that hypertensive patients had significantly higher platelet volume and rate of ADP-induced platelets aggregation compared to the controls. In vitro, Primary human platelets were cultured under standard (0 mmHg) or increased (120, 180, 240 mmHg) hydrostatic pressure for 18 h. Exposure to elevated pressure was associated with morphological changes in platelets. Platelet aggregation and PAC-1 (the active confirmation of GPIIb/IIIa) binding were increased, CD40L was translocated from cytoplasm to the surface of platelet and soluble CD40L (sCD40L) was released into the medium in response to elevated hydrostatic pressure (180 and 240 mmHg). The PPARγ activity was up-regulated as the pressure was increased from 120 mmHg to 180 mmHg. Pressure-induced platelet aggregation, PAC-1 binding, and translocation and release of CD40L were all attenuated by the PPARγ agonist Thiazolidinediones (TZDs). These results demonstrate that platelet activation and aggregation are increased by exposure to elevated pressure and that PPARγ may modulate platelet activation induced by high hydrostatic pressure.

摘要

高血压与血小板过度活跃有关,但流体静压对血小板功能的直接影响仍不清楚。本研究旨在探讨流体静压升高是否导致血小板活化,并探讨过氧化物酶体增殖物激活受体γ(PPARγ)的潜在作用。我们观察到,与对照组相比,高血压患者的血小板体积和ADP诱导的血小板聚集率显著更高。在体外,将原代人血小板在标准(0 mmHg)或升高(120、180、240 mmHg)的流体静压下培养18小时。暴露于升高的压力与血小板的形态变化有关。响应于升高的流体静压(180和240 mmHg),血小板聚集和PAC-1(GPIIb/IIIa的活性形式)结合增加,CD40L从细胞质转运到血小板表面,可溶性CD40L(sCD40L)释放到培养基中。随着压力从120 mmHg增加到180 mmHg,PPARγ活性上调。PPARγ激动剂噻唑烷二酮(TZDs)减弱了压力诱导的血小板聚集、PAC-1结合以及CD40L的转运和释放。这些结果表明,暴露于升高的压力会增加血小板活化和聚集,并且PPARγ可能调节高流体静压诱导的血小板活化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/814c041755e3/pone.0089654.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/bc6fa116fbee/pone.0089654.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/7e6690703d4a/pone.0089654.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/7341dcd4bc9a/pone.0089654.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/30ed4c39dee4/pone.0089654.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/4f8276a0a7d9/pone.0089654.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/814c041755e3/pone.0089654.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/bc6fa116fbee/pone.0089654.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/7e6690703d4a/pone.0089654.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/7341dcd4bc9a/pone.0089654.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/30ed4c39dee4/pone.0089654.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/4f8276a0a7d9/pone.0089654.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f44a/3938478/814c041755e3/pone.0089654.g006.jpg

相似文献

1
PPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activity.过氧化物酶体增殖物激活受体γ配体可降低流体静压诱导的血小板聚集和促炎活性。
PLoS One. 2014 Feb 28;9(2):e89654. doi: 10.1371/journal.pone.0089654. eCollection 2014.
2
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.人骨髓巨核细胞和血小板表达过氧化物酶体增殖物激活受体γ(PPARγ),且PPARγ激动剂可抑制血小板释放CD40配体和血栓素。
Blood. 2004 Sep 1;104(5):1361-8. doi: 10.1182/blood-2004-03-0926. Epub 2004 May 6.
3
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.血小板中可溶性CD40L的释放受糖蛋白IIb/IIIa和肌动蛋白聚合作用的调节。
J Am Coll Cardiol. 2004 Jun 16;43(12):2319-25. doi: 10.1016/j.jacc.2003.12.055.
4
Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitus.PPARγ 激动剂对 2 型糖尿病患者止血激活的多效作用。
Curr Vasc Pharmacol. 2013 May;11(3):338-51. doi: 10.2174/1570161111311030008.
5
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.过氧化物酶体增殖物激活受体γ和视黄酸X受体转录因子从活化的人血小板中释放并脱落到微粒中。
Thromb Haemost. 2008 Jan;99(1):86-95. doi: 10.1160/TH07-05-0328.
6
Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets.硝苯地平下调胶原刺激的人血小板中CD40L/sCD40L信号传导的机制
PLoS One. 2015 May 13;10(5):e0127054. doi: 10.1371/journal.pone.0127054. eCollection 2015.
7
Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.稳定型冠状动脉疾病患者血小板糖蛋白 IIb-IIIa 阻断后 CD40L(CD154)和 CD62P(p-选择素)表面表达的调节。
Thromb Res. 2010 Jan;125(1):44-52. doi: 10.1016/j.thromres.2009.04.017. Epub 2009 May 31.
8
Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.血小板作为过氧化物酶体增殖物激活受体γ配体的新靶点:对炎症、糖尿病和心血管疾病的影响
BioDrugs. 2006;20(4):231-41. doi: 10.2165/00063030-200620040-00004.
9
CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent.CD40L 通过 NF-κB 激活对血小板的预刺激作用依赖于 CD40 和 TAK1。
J Am Heart Assoc. 2018 Dec 4;7(23):e03677. doi: 10.1161/JAHA.118.009636.
10
Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.糖蛋白IIb/IIIa拮抗剂和阿司匹林对血小板刺激过程中可溶性CD40配体释放的抑制作用。
Circulation. 2003 Mar 4;107(8):1123-8. doi: 10.1161/01.cir.0000053559.46158.ad.

引用本文的文献

1
Transcription factors in megakaryocytes and platelets.巨核细胞和血小板中的转录因子。
Front Immunol. 2023 Mar 9;14:1140501. doi: 10.3389/fimmu.2023.1140501. eCollection 2023.
2
Endothelial Cell-Targeted Deletion of PPAR Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue.内皮细胞靶向敲除 PPAR 阻断罗格列酮诱导的脂肪组织血浆容量扩张和血管重塑。
J Pharmacol Exp Ther. 2019 Mar;368(3):514-523. doi: 10.1124/jpet.118.250985. Epub 2019 Jan 3.
3
PPARγ and the Innate Immune System Mediate the Resolution of Inflammation.

本文引用的文献

1
CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications.CD40-CD40L:在 2 型糖尿病及其并发症中连接胰腺、脂肪组织和血管炎症。
Diab Vasc Dis Res. 2013 Mar;10(2):115-22. doi: 10.1177/1479164112455817. Epub 2012 Sep 10.
2
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.基质内皮细胞通过 TNF 相关因子 BAFF、APRIL 和 CD40L 与慢性淋巴细胞白血病细胞建立双向交流。
J Immunol. 2012 Jun 15;188(12):6071-83. doi: 10.4049/jimmunol.1102066. Epub 2012 May 16.
3
过氧化物酶体增殖物激活受体γ与固有免疫系统介导炎症消退。
PPAR Res. 2015;2015:549691. doi: 10.1155/2015/549691. Epub 2015 Dec 2.
4
Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles.打破常规:无核血小板和血小板衍生微粒中的转录因子。
Front Immunol. 2015 Feb 13;6:48. doi: 10.3389/fimmu.2015.00048. eCollection 2015.
PPAR- γ agonist in treatment of diabetes: cardiovascular safety considerations.
过氧化物酶体增殖物激活受体γ激动剂治疗糖尿病:心血管安全性考量
Cardiovasc Hematol Agents Med Chem. 2012 Jun;10(2):124-34. doi: 10.2174/187152512800388948.
4
Antiplatelet agents and anticoagulants for hypertension.用于高血压的抗血小板药物和抗凝剂。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003186. doi: 10.1002/14651858.CD003186.pub3.
5
Microvascular thrombosis and CD40/CD40L signaling.微血管血栓形成与 CD40/CD40L 信号通路。
J Thromb Haemost. 2011 Mar;9(3):574-81. doi: 10.1111/j.1538-7836.2010.04176.x.
6
Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study.急性心肌梗死吸烟者血浆中可溶性CD40配体的浓度:一项初步研究。
Heart Vessels. 2011 Mar;26(2):131-7. doi: 10.1007/s00380-010-0036-x. Epub 2010 Oct 27.
7
The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.动脉粥样硬化中CD154-CD40-TRAF相互作用的免疫生物学
Semin Immunol. 2009 Oct;21(5):308-12. doi: 10.1016/j.smim.2009.06.004. Epub 2009 Jul 17.
8
A CD40-CD154 interaction in tissue fibrosis.组织纤维化中的CD40-CD154相互作用。
Arthritis Rheum. 2008 Nov;58(11):3562-73. doi: 10.1002/art.23994.
9
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.过氧化物酶体增殖物激活受体γ和视黄酸X受体转录因子从活化的人血小板中释放并脱落到微粒中。
Thromb Haemost. 2008 Jan;99(1):86-95. doi: 10.1160/TH07-05-0328.
10
CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets.CD40与CD40配体的相互作用激活胰岛中的促炎途径。
Diabetes. 2006 Sep;55(9):2437-45. doi: 10.2337/db05-1673.